TrialPloS one2014

Plasma YKL-40 in patients with metastatic colorectal cancer treated with first line oxaliplatin-based regimen with or without cetuximab: RESULTS from the NORDIC VII Study.

Line S Tarpgaard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.